Trials
8 active
18 in total · 6 in the EU
What this is
- How it works
- An antibody: a lab-made immune protein built to latch onto one target in the body.-mab: monoclonal antibodies WHO name stem
- Tested for
- Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Children and Adolescents Aged 6 to 18 With Moderate-to-Severe Plaque Psoriasis, Active Non-radiographic Axial Spondyloarthritis
- Main trialPhase 4
- “This is a prospective, single-arm, multicenter, Phase IV study of 1564 patients with moderate-to-severe chronic plaque psoriasis to evaluate the efficacy and safety of Vunakizumab in patients with moderate-to-severe plaque psoriasis who have converted from other biologics. To explore the efficacy of difficult-to-treat area, patient satisfaction and patient-reported outcomes (PRO).”In the company’s words, NCT06779097 on ClinicalTrials.gov
- Other names
- SHR-1314
Other drugs for Moderate to Severe Plaque Psoriasis
- ZasocitinibTakeda · Phase 3
- TQH3906Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Phase 3
- BimekizumabUCB Biopharma SRL · Phase 3
- PiclidenosonCan-Fite BioPharma · Phase 3
- Total coumarin creamPsoriasis Research Institute of Guangzhou · Phase 3
- RisankizumabAbbVie · Phase 3
Coming up2
- Mar 2027Phase 4 trial completes · ClinicalTrials.gov
- Feb 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials18
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 4Not yet recruiting | Mar 2027 | Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis | |
| Phase 3Active, not recruiting | 5 Jun 2026 | A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis | |
| Phase 3Not yet recruiting | Jul 2026 | The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis | |
| Phase 3Recruiting | Feb 2028 | A Trial of SHR-1314 Injection in Adult Patients With Active Non-radiographic Axial Spondyloarthritis | |
| Phase 3Unknown | 30 Aug 2023 | Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis | |
| Phase 2/3Completed | 3 Nov 2023 | Efficacy and Safety of SHR-1314 in Patients With Active Ankylosing Spondylitis | |
| Phase 2Unknown | 25 Dec 2021 | A Phase II Study to Evaluate the Efficacy and Safety of SHR-1314 in Lupus Nephritis | |
| Phase 2Terminated | 22 Aug 2023 | Efficacy and Safety of SHR-1314 by Subcutaneous Injection in Active Moderate to Severe Graves' Orbitopathy Patients | |
| Phase 2Completed | 5 Jun 2024 | Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis | |
| Phase 1/2Completed | 31 Aug 2020 | Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis | |
| Phase 1Completed | 14 Jan 2020 | Safety, Tolerability and PK of SHR1314 in axSpA | |
| Phase 1Completed | 13 May 2024 | A Clinical Study to Compare the Safety and Pharmacokinetics of SHR-1314 Injection in Healthy Subjects at Different Specifications Devices | |
| Phase 3Authorised | not given | A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients | |
| Phase 3Authorised | not given | A randomised, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of PQ Birch in subjects with seasonal allergic rhinitis and/or rhinoconjunctivitis induced by birch pollen exposure | |
| Phase 3/4Ended | not given | The effects of the manipulation of 5-HT, DA and NA on exercise-induced fatigue and brain activation | |
| Phase 2Not authorised | not given | A RAndomised Placebo Controlled Trial - to Explore the Efficacy and Mechanism of Action of Tezepelumab in EGPA- RACE-MATE | |
| Phase 2Authorised | not given | Tocotrienol and bevacizumab in metastatic colorectal cancer. A randomized phase II marker trial | |
| Phase 3Authorised | not given | Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter randomized controlled non-inferiority study (RIFREE) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026